/
HURA
$2.30-$0.04 (-1.71%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$149.0M
64M shares
52-week range
$0.41 – $3.43
63% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-4.00
TuHURA Biosciences, Inc. Common Stock
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
www.tuhurabio.com- Employees
- 22
- IPO / List date
- Oct 18, 2024
- HQ
- TAMPA, FL
Held by traders on TradeandTell
No one on the platform currently holds HURA.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in HURA as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-10-18 | 2-for-1 |
Recent trades on TradeandTell
No one on the platform has traded HURA yet.
